Profit Or Loss [Abstract]

ABIONYX Pharma - Filing #2810725

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
4 640 EUR
5 252 EUR
Cost of sales
4 022 EUR
4 616 EUR
Profit (loss) from operating activities
3 412 EUR
4 109 EUR
Finance income
196,000 EUR
165,000 EUR
Finance costs
302,000 EUR
262,000 EUR
Tax expense (income)
0 EUR
0 EUR
Profit (loss)
0 EUR
3 518 EUR
0 EUR
0 EUR
3 518 EUR
0 EUR
0 EUR
0 EUR
0 EUR
0 EUR
4 206 EUR
0 EUR
4 206 EUR
0 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
12.00
15.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
12.00
15.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.